Skip to main content
Clinical Trials/JPRN-UMIN000011623
JPRN-UMIN000011623
Completed
未知

Efficacy of steroid therapy for prevention of recurrent cerebral amyloid angiopathy-related hemorrhage. - Efficacy of steroid therapy for prevention of recurrent cerebral amyloid angiopathy-related hemorrhage.

Aizawa Hospital0 sites20 target enrollmentSeptember 2, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Cerebral amyloid angiopathy
Sponsor
Aizawa Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 2, 2013
End Date
March 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who have met these exclusion criteria should be excluded. Age is younger than 41 years old or older than 86 years old when informed consent was obtained. Patients who have uncontrolled hypertension (systolic blood pressure\>\=160mmHg or diastolic blood pressure\>\=100mmHg), taken antithrombotic medication (antiplatelet or anticoagulant drug), abnormal glucose tolerance (HbA1c\>\=6\.5%(NGSP)). Patients who may have difficulty in adherence to continuous and regular medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials